Expert Review of Hematology

• 

  Publication Venue For

  • Palliative care for patients with hematologic malignancies: are we meeting patients' needs early enough?.  15:813-820. 2022
  • Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis..  15:167-173. 2022
  • Selinexor for the treatment of patients with previously treated multiple myeloma..  14:697-706. 2021
  • Palliative care in hematologic malignancies: a multidisciplinary approach..  13:223-231. 2020
  • Current perspectives on the treatment of double hit lymphoma..  12:507-514. 2019
  • Fertility challenges for women with sickle cell disease..  10:891-901. 2017
  • Should modulation of p50 be a therapeutic target in the critically ill?.  10:449-458. 2017
  • Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents..  7:617-633. 2014
  • Engineering a new generation of hemostatic agents: highlights of the Scientific Session on Hemostasis at the 2013 meeting of the American Society of Hematology..  7:343-345. 2014
  • Clinical causes and treatment of the thrombotic storm..  5:653-659. 2012
  • Clinical causes and treatment of the thrombotic storm..  5:653-659. 2012
  • Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation..  5:291-302. 2012
  • The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease..  4:597-606. 2011
  • Iron overload and allogeneic hematopoietic stem-cell transplantation..  4:71-80. 2011
  • Many, but not all, outcome studies support exclusion of female plasma from the blood supply..  3:551-558. 2010
  • Umbilical cord blood: biology and transplantation..  2:197-208. 2009
  • Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation..  9:115-122. 2016